搜索
Immunome Inc
IMNM添加自选
23.610USD
+2.120+9.87%
收盘 07/02, 13:00（美东）报价延迟15分钟
2.67B总市值
亏损市盈率 TTM
股东统计
更新时间: 5月11日 周一
更新时间: 5月11日 周一
持股股东
股东类型
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
14.60%
T. Rowe Price Investment Management, Inc.
11.85%
Point72 Asset Management, L.P.
6.21%
BlackRock Institutional Trust Company, N.A.
5.61%
Redmile Group, LLC
5.05%
其他
56.67%
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
14.60%
T. Rowe Price Investment Management, Inc.
11.85%
Point72 Asset Management, L.P.
6.21%
BlackRock Institutional Trust Company, N.A.
5.61%
Redmile Group, LLC
5.05%
其他
56.67%
股东类型
持股股东
占比
Investment Advisor
56.69%
Investment Advisor/Hedge Fund
26.03%
Hedge Fund
14.33%
Corporation
6.00%
Research Firm
3.19%
Venture Capital
2.09%
Individual Investor
1.33%
Bank and Trust
0.37%
Pension Fund
0.18%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
380
116.25M
102.66%
+15.81M
2025Q4
349
92.88M
84.18%
+6.06M
2025Q3
328
84.54M
92.66%
-1.54M
2025Q2
326
85.20M
99.48%
+13.79M
2025Q1
320
89.38M
113.71%
+17.13M
2024Q4
278
64.18M
84.45%
+3.64M
2024Q3
252
62.39M
103.49%
+7.38M
2024Q2
228
58.25M
97.90%
+16.13M
2024Q1
182
46.83M
84.41%
+22.74M
2023Q4
113
32.29M
78.79%
+19.76M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Fidelity Management & Research Company LLC
16.54M
14.62%
+3.48M
+26.67%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
13.42M
11.86%
+2.78M
+26.09%
Dec 31, 2025
Point72 Asset Management, L.P.
7.03M
6.22%
+2.21M
+45.82%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
6.35M
5.61%
+1.12M
+21.32%
Dec 31, 2025
Redmile Group, LLC
5.72M
5.05%
+695.00K
+13.84%
Dec 31, 2025
PRIMECAP Management Company
4.69M
4.14%
+1.67M
+55.25%
Dec 31, 2025
Enavate Sciences GP, LLC
4.77M
4.21%
--
--
Dec 31, 2025
State Street Investment Management (US)
3.87M
3.42%
+1.06M
+37.95%
Dec 31, 2025
Driehaus Capital Management, LLC
3.71M
3.28%
+3.01M
+432.05%
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Genomics Immunology and Healthcare ETF
2.62%
Tema Oncology ETF
1.97%
WisdomTree BioRevolution Fund
1.53%
Virtus LifeSci Biotech Clinical Trials ETF
1.11%
ALPS Medical Breakthroughs ETF
0.55%
State Street SPDR S&P Biotech ETF
0.34%
iShares Micro-Cap ETF
0.24%
Direxion Daily S&P Biotech Bull 3X Shares
0.21%
iShares Russell 2000 Growth ETF
0.07%
iShares US Tech Breakthrough Multisector ETF
0.06%
查看更多
iShares Genomics Immunology and Healthcare ETF
占比2.62%
Tema Oncology ETF
占比1.97%
WisdomTree BioRevolution Fund
占比1.53%
Virtus LifeSci Biotech Clinical Trials ETF
占比1.11%
ALPS Medical Breakthroughs ETF
占比0.55%
State Street SPDR S&P Biotech ETF
占比0.34%
iShares Micro-Cap ETF
占比0.24%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.21%
iShares Russell 2000 Growth ETF
占比0.07%
iShares US Tech Breakthrough Multisector ETF
占比0.06%